RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Abbott Laboratories Stock

Abbott Laboratories Net Income 2025

Abbott Laboratories Net Income

9.08 B USD

Ticker

ABT

ISIN

US0028241000

WKN

850103

In 2025, Abbott Laboratories's profit amounted to 9.08 B USD, a -32.22% increase from the 13.4 B USD profit recorded in the previous year.

The Abbott Laboratories Net Income history

YEARNET INCOME (B USD)
2030e14.55
2029e13.07
2028e12.11
2027e11.09
2026e10.01
2025e9.08
202413.4
20235.72
20226.93
20217.07
20204.5
20193.69
20182.37
20170.48
20161.4
20154.42
20142.28
20132.58
20125.96
20114.73
20104.63
20095.75
20084.88
20073.61
20061.72
20053.37

Abbott Laboratories Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Abbott Laboratories, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Abbott Laboratories from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Abbott Laboratories’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Abbott Laboratories. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Abbott Laboratories’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Abbott Laboratories’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Abbott Laboratories’s growth potential.

Abbott Laboratories Revenue, EBIT and net profit per share

DateAbbott Laboratories RevenueAbbott Laboratories EBITAbbott Laboratories Net Income
2030e65.76 B undefined0 undefined14.55 B undefined
2029e59.81 B undefined15.85 B undefined13.07 B undefined
2028e55.64 B undefined14.2 B undefined12.11 B undefined
2027e52.26 B undefined12.95 B undefined11.09 B undefined
2026e48.68 B undefined11.72 B undefined10.01 B undefined
2025e45.14 B undefined10.53 B undefined9.08 B undefined
202441.95 B undefined6.99 B undefined13.4 B undefined
202340.11 B undefined6.72 B undefined5.72 B undefined
202243.65 B undefined8.71 B undefined6.93 B undefined
202143.08 B undefined8.59 B undefined7.07 B undefined
202034.61 B undefined5.43 B undefined4.5 B undefined
201931.9 B undefined4.67 B undefined3.69 B undefined
201830.58 B undefined3.73 B undefined2.37 B undefined
201727.39 B undefined1.87 B undefined477 M undefined
201620.85 B undefined3.06 B undefined1.4 B undefined
201520.41 B undefined2.96 B undefined4.42 B undefined
201420.25 B undefined2.76 B undefined2.28 B undefined
201319.66 B undefined2.13 B undefined2.58 B undefined
201219.05 B undefined1.36 B undefined5.96 B undefined
201121.41 B undefined1.59 B undefined4.73 B undefined
201035.17 B undefined6.46 B undefined4.63 B undefined
200930.77 B undefined6.61 B undefined5.75 B undefined
200829.53 B undefined5.83 B undefined4.88 B undefined
200725.91 B undefined4.58 B undefined3.61 B undefined
200622.48 B undefined4.06 B undefined1.72 B undefined
200522.34 B undefined4.38 B undefined3.37 B undefined

Abbott Laboratories stock margins

The Abbott Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abbott Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abbott Laboratories.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Abbott Laboratories's sales revenue. A higher gross margin percentage indicates that the Abbott Laboratories retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Abbott Laboratories's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Abbott Laboratories's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Abbott Laboratories's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Abbott Laboratories. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Abbott Laboratories's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Abbott Laboratories Margin History

Abbott Laboratories Gross marginAbbott Laboratories Profit marginAbbott Laboratories EBIT marginAbbott Laboratories Profit margin
2030e55.56 %0 %22.12 %
2029e55.56 %26.49 %21.86 %
2028e55.56 %25.52 %21.77 %
2027e55.56 %24.77 %21.22 %
2026e55.56 %24.08 %20.57 %
2025e55.56 %23.33 %20.12 %
202455.56 %16.67 %31.95 %
202355.32 %16.76 %14.27 %
202256.28 %19.95 %15.88 %
202157.07 %19.94 %16.42 %
202056.75 %15.69 %12.99 %
201958.64 %14.64 %11.56 %
201858.5 %12.2 %7.74 %
201754.74 %6.83 %1.74 %
201656.43 %14.66 %6.71 %
201557.22 %14.52 %21.68 %
201454.57 %13.65 %11.28 %
201353.23 %10.85 %13.1 %
201253.29 %7.14 %31.3 %
201153 %7.4 %22.09 %
201058.3 %18.36 %13.15 %
200957.06 %21.48 %18.68 %
200857.29 %19.73 %16.53 %
200755.92 %17.67 %13.92 %
200656.33 %18.05 %7.64 %
200552.36 %19.61 %15.1 %

Abbott Laboratories Aktienanalyse

What does Abbott Laboratories do?

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Abbott Laboratories's Profit Margins

The profit margins of Abbott Laboratories represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Abbott Laboratories's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Abbott Laboratories's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Abbott Laboratories's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Abbott Laboratories’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Abbott Laboratories stock

How much profit has Abbott Laboratories made this year?

Abbott Laboratories has made 9.08 B USD this year.

How has the profit developed compared to last year?

The profit has increased by -32.22% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Abbott Laboratories publish its earnings?

Abbott Laboratories publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Abbott Laboratories?

The profits of Abbott Laboratories are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Abbott Laboratories?

You can learn more about the earnings of Abbott Laboratories by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of 2.24 USD . This corresponds to a dividend yield of about 1.68 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.8 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is 1.68 %.

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of November, March, May, August.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 26 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.8 USD are expected. This corresponds to a dividend yield of 2.1 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 8/15/2025 amounting to 0.59 USD, you needed to have the stock in your portfolio before the ex-date on 7/15/2025.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 8/15/2025.

What was the dividend of Abbott Laboratories in the year 2024?

In the year 2024, Abbott Laboratories distributed 2.08 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbott Laboratories stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbott Laboratories

Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.